ClinicalTrials.Veeva

Menu

Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients

I

Institute of Hematology & Blood Diseases Hospital, China

Status

Not yet enrolling

Conditions

Carbapenem-resistant Enterobacterales
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Study type

Observational

Funder types

Other

Identifiers

NCT07324291
QTJC2024065

Details and patient eligibility

About

The goal of this observational study is to characterize the clinical features of metallo-β-lactamase-producing carbapenem-resistant Enterobacterales (MBL-CRE) colonization and subsequent infection in patients after allogeneic hematopoietic stem cell transplantation (HSCT). The study aims to estimate the incidence of perianal MBL-CRE colonization, the proportion of subsequent infections, the associated risk factors, mortality, and the underlying antibiotic resistance mechanisms.

The main questions this study seeks to answer are:

  1. What is the incidence of perianal MBL-CRE colonization following allogeneic HSCT?
  2. Among colonized patients, what proportion subsequently develop MBL-CRE infections?
  3. What are the risk factors for colonization and infection, the patterns of antimicrobial resistance, and the mortality among infected patients? Participants will undergo perianal swab screening for CRE as part of their routine post-transplant care. MBL-CRE isolates identified from perianal swabs will undergo antimicrobial resistance genomic analysis to investigate bacterial transmission dynamics and resistance mechanisms.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (≥18 years) who received allogeneic hematopoietic stem cell transplantation;

Exclusion criteria

  • Engraftment failure.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems